תאריך: 05/08/2011
The appropriate classification of hypoplastic BM disorders in young patients continues to be a great challenge. Accurate diagnosis is the prerequisite for medical and genetic counseling, surveillance, and therapy options for these children and adolescents. Because most patients with BM failure will require allogeneic hematopoietic stem cell transplantation (HSCT), the timing of the procedure, choice of donor, preparative regimen, and estimation of complications will
greatly differ among the various disease entities.
